Silver Book Fact

The annual direct medical costs (including outpatient, inpatient, and prescription drug services) for Americans age 40 and older with diabetic retinopathy is $493 million.

Rein, David B., Ping Zhang, Kathleen E. Wirth, Paul P. Lee, Thomas J. Hoerger, Nancy McCall, Ronald Klein, James M. Tielsch, Sandeep Vijan, and Jinan Saaddine. The Economic Burden of Major Adult Visual Disorders in the United States. Arch Opthalmol. 2006; 124(12): 1754-60. http://archopht.ama-assn.org/cgi/content/abstract/124/12/1754

Reference

Title
The Economic Burden of Major Adult Visual Disorders in the United States
Publication
Arch Opthalmol
Publication Date
2006
Authors
Rein, David B., Ping Zhang, Kathleen E. Wirth, Paul P. Lee, Thomas J. Hoerger, Nancy McCall, Ronald Klein, James M. Tielsch, Sandeep Vijan, and Jinan Saaddine
Volume & Issue
Volume 124, Issue 12
Pages
1754-60
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Quality of life of diabetic retinopathy patients
    A study evaluating quality of life using utility values, found that diabetic retinopathy patients with best-corrected visual acuity of 20/20 and 20/25, were willing to trade 15% of their remaining…  
  • Future Impact of DR
    The rise of DR will disproportionately impacting the poorest populations, since 80% of people with diabetes live in low-middle income countries.  
  • An estimated 4.1 million Americans age 40 and older have diabetic retinopathy.  
  • Number of Patients Aged 65 and Older Using Medical Services, Medications and Vitamins  
  • Risk of DR
    The risk of DR increases the longer a person has diabetes.  More than 75% of people who have diabetes for more than 20 years will have some form of DR.